Alerts

Recall - pumps will cease operation on 1 January 2016

Recall - risk of adverse events due to unacceptably high level of arsenic

Hazard alert - multiple potential safety issues

Recall for product correction - fire risk from faulty component

Recall for product correction - fire risk from faulty component

The following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)

Recall - bottles supplied without child-resistant caps

Recall for product correction - risk of sparking or fire due to damaged or cut wire

Recall - counterfeit products may have defects and not be effective

Recall for product correction - potential for insulin to not be delivered as intended

Update - recall for product correction - advertisements published to inform all affected users

Recall - incorrect contact lenses supplied to some consumers

Recall - risk of adverse events due to potential dilution

Hazard alert - higher than expected revision rate

Hazard alert - potential for implant failure due to loosening

Recall for product correction - bottles supplied without child-resistant caps

Recall - bottles supplied without child-resistant caps

Recall for product correction - bottles supplied without child-resistant caps

Recall - bottles supplied without child-resistant caps

Recall - bottles supplied without child-resistant caps

Hazard alert - potential for implant failure due to poor fixation

Hazard alert - updated instructions to reduce risk of complications

Recall for product correction - Update to instructions to prevent blood loss if unit malfunctions

Hazard alert - higher than expected revision rate

Recall for product correction - risk of peritonitis due to separated, partially protruding or missing sponge